| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 388.358.834 $ | +166.762.368 $ | +137,6 % | 8 | 223.767.824 $ | -33.723.950 $ | +13,5 % | 7 | 291.828.562 $ | +112.509.288 $ | +58,3 % | 10 | ||||
| Dianthus Therapeutics, Inc. /DE/ | DNTH | → 0 | Schwach | 176.583.121 $ | +89.869.698 $ | +103,6 % | 1 | 86.713.423 $ | -39.371.217 $ | -31,2 % | 1 | 126.084.640 $ | +93.614.376 $ | +288,3 % | 1 |
| CG Oncology, Inc. | CGON | → 0 | Neutral | 87.236.001 $ | +26.089.539 $ | +42,7 % | 1 | 61.146.462 $ | -3.337.750 $ | -5,2 % | 1 | 64.484.212 $ | +25.485.720 $ | +65,4 % | 1 |
| Oruka Therapeutics, Inc. | ORKA | → 0 | Neutral | 37.298.797 $ | +17.281.346 $ | +86,3 % | 1 | 20.017.451 $ | +7.317.497 $ | +57,6 % | 1 | 12.699.954 $ | +8.752.644 $ | +221,7 % | 1 |
| Perspective Therapeutics, Inc. | CATX | → 0 | Neutral | 25.228.496 $ | +16.398.980 $ | +185,7 % | 1 | 10.269.533 $ | +3.875.963 $ | +60,6 % | 1 | ||||
| Jade Biosciences, Inc. | JBIO | → 0 | Schwach | 19.679.947 $ | -1.932.977 $ | -8,9 % | 1 | 21.612.924 $ | +11.885.309 $ | +122,2 % | 1 | ||||
| Medtronic plc | MDT | → 0 | Neutral | 10.336.056 $ | -7.816.688 $ | -43,1 % | 1 | 18.152.744 $ | +18.152.744 $ | 1 | |||||
| BOSTON SCIENTIFIC CORP | BSX | → 0 | Neutral | 10.917.575 $ | -5.123.034 $ | -31,9 % | 1 | 16.040.609 $ | -18.523.929 $ | -53,6 % | 1 | ||||
| Enliven Therapeutics, Inc. | ELVN | → 0 | Neutral | 15.680.000 $ | +13.519.380 $ | +625,7 % | 1 | ||||||||
| TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | → 0 | Neutral | 13.557.012 $ | +533.079 $ | +4,1 % | 1 | 13.023.933 $ | +2.721.933 $ | +26,4 % | 1 | 10.302.000 $ | -1.254.020 $ | -10,9 % | 1 |
| Context Therapeutics Inc. | CNTX | → 0 | Neutral | 13.095.460 $ | +5.003.323 $ | +61,8 % | 1 | ||||||||
| BRISTOL MYERS SQUIBB CO | BMY | → 0 | Stark | 11.617.760 $ | +11.617.760 $ | 1 | |||||||||
| Natera, Inc. | NTRA | → 0 | Neutral | 11.332.288 $ | -22.337.454 $ | -66,3 % | 1 | ||||||||
| DANAHER CORP /DE/ | DHR | → 0 | Schwach | 10.844.822 $ | -6.874.516 $ | -38,8 % | 1 | ||||||||
| 388.358.834 $ | +166.762.368 $ | +137,6 % | 8 | 223.767.824 $ | -33.723.950 $ | +13,5 % | 7 | 291.828.562 $ | +112.509.288 $ | +58,3 % | 10 | ||||